Ambiq Micro, Inc.
For the period ended Sep 30, 2026. Filed Nov 10, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 10, 2026
AMBQ$45.24-1.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
(in thousands)
| For the nine months ended September 30, | ||
|---|---|---|
| 2026 | 2025 | |
| Cash flows from operating activities | ||
| Net loss | $(24,342) | $(25,782) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | 5,339 | 5,568 |
| Stock-based compensation | 10,936 | 3,684 |
| Gain on receipt of nonmonetary tangible assets | — | (1,600) |
| Change in right-of-use assets | 610 | 606 |
| Change in warrant valuations and cancellations | — | 60 |
| Other | — | (110) |
| Changes in operating assets and liabilities | ||
| Accounts receivable | (11,734) | 3,484 |
| Inventories | (13,114) | (1,118) |
| Prepaid expenses and other assets | (986) | (823) |
| Other long-term assets | 23 | — |
| Accounts payable | 1,324 | (956) |
| Accrued and other current liabilities | 7,224 | 1,584 |
| Other long-term liabilities | (662) | (174) |
| Net cash used in operating activities | (25,382) | (15,577) |
| Cash flows from investing activities | ||
| Purchase of intangible assets | (6,281) | (3,687) |
| Purchases of property, equipment and software | (1,404) | (1,162) |
| Net cash used in investing activities | (7,685) | (4,849) |
| Cash flows from financing activities | ||
| Proceeds from issuance of common stock in connection with follow-on offerings, net of underwriting discounts and commissions | 245,468 | — |
| Proceeds from issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions | — | 102,672 |
| Payment of deferred offering costs | (2,186) | (2,829) |
| Proceeds from exercise of stock options | 9,893 | 353 |
| Proceeds from exercise of warrants | 3,010 | 5,702 |
| Net cash provided by financing activities | 256,185 | 105,898 |
| Effect of exchange rate changes on cash and cash equivalents | 59 | 37 |
| Net increase in cash and cash equivalents | 223,177 | 85,509 |
| Cash and cash equivalents at beginning of period | 140,275 | 60,981 |
| Cash and cash equivalents at end of period | $363,452 | $146,490 |
| Supplemental disclosure of non-cash investing and financing activities | ||
| Intangible assets in accounts payable, accrued and other long-term liabilities | 4,830 | 7,904 |
| Gain on receipt of nonmonetary tangible assets | — | 1,600 |
| Right-of-use assets obtained in exchange for new operating lease liabilities | 3,016 | 383 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.